CLSA Events

Bayer China Partnering Day

Bayer Heathcare

Partnering Areas of Interest
Phase II through Marketed Products

Cardiovascular ‚Ä¢ Diabetes ‚Ä¢ Oncology ‚Ä¢ Neurology
Respiratory ‚Ä¢ Gastrointestinal ‚Ä¢ Anti-Infective

Bayer Healthcare China, one of the top 3 healthcare companies in the China market, is actively seeking collaborative drug commercialization and promotion partnerships with U.S. life sciences companies to capture the major growth opportunity in China. Additionally, Bayer as the industry player is also seeking collaboration partnerships with external agencies to co-cultivate promising companies to achieve win-win in China.

Bayer Healthcare China would like to sincerely invite you to a special closed door event to share insights of successful business strategies in the Chinese market and discover new partnership opportunities in China.

At this event, the top management team from Bayer HealthCare China will showcase the sales and marketing powerhouse and knowledge on the successful launch of new products in China. Top Bayer HealthCare China executives, including the Regional Head (CEO), Chief Marketing Officer, Chief Medical Officer, and Head of Strategy and Business Development will present innovative strategies and unique insights to drive growth in the pharmaceutical industry in China and share valuable experiences with you.

This event will benefit you by offering the following:

  • The latest trends and opportunities in China’s pharmaceutical sector
  • Bayer Healthcare’s aspirations and strategic visions to sustain the leading position in China’s pharma industry
  • Key success factors to win in China’s life sciences sector
  • Dynamic and open partnership opportunities to capitalize on the market potential

Why Partner with Bayer HealthCare in China?

The Chinese pharmaceutical industry is currently growing at a double digit rate and will become the 3rd largest market in the world, the manufacturer sales likely to grow from $ 16 billion in 2007 to $ 85 billion in 2015 with CAGR 22%.

Bayer Healthcare has a presence in China since 1936 and grew to a leading pharmaceutical company in China with annual sales reaching $14 billion. Bayer HealthCare is one of the largest sales forces in China. Bayer healthcare has 4,000 medical representatives to cover 12,000 hospitals (60% of hospitals in China) in 485 cities (75% of cities in China).

Confirmed Participants

Chris Lee
CEO, BHC China / Hongkong

Xin Wu
Head of Strategy and Business Development

Min Irwin
VP, Medical Head of China/Hong Kong

Frank Wang
Chief Marketing Officer

Mark Chen
BD Manager

Betty Huang
BD Manager

Vivian Tu
BD Manager

Joanna Yan
Associate Manager of Project Coordination

Lily Yu
BD Manager

Sarah Zhang
Senior Strategy Manager

Bayer China Partnering Day
In collaboration with BIOCOM
When: Monday, May 14, 2012
5:00PM – 7:00PM
Opening Reception (by invitation)
Tuesday, May 15, 2012
8:00AM– 8:30AM
Breakfast and networking (open to general attendance)
8:30AM – 10:30AM
Keynote Address: Bayer HealthCare (China) as a Partner of Choice (open to general attendance)
10:30AM – 4:30PM
One-on-one meetings with companies (by appointment only)
Where: Marriott San Mateo
1770 South Amphlett Boulevard
San Mateo, CA 94402
Admission: Free to Attend
Attire: Business attire suggested